ItaiDanovitchMDMBA

Addiction

Chairman, Dept of Psychiatry and Behavioral Neurosciences, Cedars-Sinai

Dr. Danovitch is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

Office
8730 Alden Drive
Suite W101
Los Angeles, CA 90048
Phone+1 310-423-8198

Fax+1 310-423-0114

Cedars-Sinai Medical CenterFellowship, Addiction Psychiatry, 2007 - 2008
New York Presbyterian Hospital (Columbia Campus)/New York State Psychiatric InstituteResidency, Psychiatry, 2003 - 2007
David Geffen School of Medicine at UCLAClass of 2003

Substance Use Treatment and Recovery Team (START) Start of enrollment: 2020 Dec 04
Completed
Not Applicable

PubMed

1 citations
Systematic review of long-acting injectable antipsychotic medications approved from 2008 to october 2024 and agents in phase 3.
Ashley Meyer, Kyla Truman, Jayant Totlani, Catherine William, Haze Brown
International Journal of Psychiatry in Medicine. 2024-12-19
Overview of Psychiatric Medications in the Pipeline in Phase III Trials as of June 1, 2024: A Systematic Review.
Waguih William IsHak, Ashley Meyer, Luiza Freire, Jayant Totlani, Nathalie Murphy
Innovations in Clinical Neuroscience. 2024-09-01
6 citations
The addiction consultation service for hospitalized patients with substance use disorder: An integrative review of the evidence.
Itai Danovitch, Samuel Korouri, Harlene Kaur, Gabrielle Messineo, Teryl Nuckols
Journal of Substance Use and Addiction Treatment. 2024-08-01

Coping with PTCD – Post-Traumatic COVID Disorder - OpinionAugust 24th, 2024
Newly Revealed Details About Matthew Perry’s Death Put Psychedelics Back in the SpotlightAugust 19th, 2024
Is This Sniffle a Cold? Or Is It Covid?December 20th, 2021
Join now to see all